Startseite
Interquim SA logo
Interquim SA

Interquim SA

780
56
14
3.8(32)

Über das Unternehmen

  • Firmenname (rechtlich): Interquim SA
  • Registrierungsland: Spain
  • Adresse: Carrer de Joan Buscallà, 10, 08173 Sant Cugat del Vallès (Barcelona)
Beschreibung:

Interquim, founded in 1978 and part of Ferrer HealthTech, develops high-value APIs with strict quality standards. Its facilities comply with European regulations, and products are exported to regulated markets. Approved by regulators and clients, Interquim supports clients from development to marketing with advanced production and quality-control labs. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

Geschäftsaktivitäten

Vertrags- & Outsourcing-Dienstleistungen

Dienstleister

Unsere Produkte & Dienstleistungen

Sell · Active Pharmaceutical Ingredients (APIs)
Rivastigmine Tartrate - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Ciclopirox Olamine - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Telmisartan - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Solifenacin Succinate - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Aripiprazole - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Tadalafil - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Imiquimod - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Lifitegrast - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Torsemide - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Celecoxib - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Rotigotine - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Roflumilast - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Pimavanserin Tartrate - Interquim SA
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Uridine Triphosphate Trisodium

Certifications

CEP-Zertifikat

GMP

DMF

FDA

Filter:
Sortieren nach:

    Keine Kommentare verfügbar.